Jacobs Levy Equity Management, Inc Harmony Biosciences Holdings, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 313,013 shares of HRMY stock, worth $10.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
313,013
Previous 224,481
39.44%
Holding current value
$10.6 Million
Previous $8.97 Million
20.09%
% of portfolio
0.04%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$223 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$197 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$160 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$76.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$53.3 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...